comparemela.com

Latest Breaking News On - Delta consulting group - Page 3 : comparemela.com

Wolters Kluwer names Carlos Rivero SVP, Global Talent

Delta Consulting Group Unveils New Strategic Advisory Board

Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results

Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results March 04, 2021 16:42 ET | Source: Cellectis Inc. Cellectis Inc. New York, New York, UNITED STATES Enrollment ongoing in 3 Cellectis-sponsored Phase 1 dose-escalation trials BALLI-01 in r/r B-ALL patients, AMELI-01 in r/r AML patients and MELANI-01 in r/r MM patients in 7 leading US clinical centers Preliminary results from our Phase 1 BALLI-01 clinical study of UCART22 in adults with r/r B-ALL presented in oral session at 2020 ASH Annual Meeting Partner Allogene Therapeutics presented initial results from Phase 1 ALPHA clinical study of licensed ALLO-501 in r/r NHL at 2020 ASCO Annual Meeting and from Phase 1 UNIVERSAL clinical study of licensed ALLO-715 in r/r MM at 2020 ASH Annual Meeting

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.